Financial reports
10-Q
2016 Q2
Quarterly report
4 Aug 16
10-Q
2016 Q1
Quarterly report
5 May 16
10-K/A
2015 FY
Annual report (amended)
29 Apr 16
10-K
2015 FY
Annual report
26 Feb 16
10-Q
2015 Q3
Quarterly report
5 Nov 15
10-Q
2015 Q2
Quarterly report
6 Aug 15
10-Q
2015 Q1
Quarterly report
7 May 15
10-K
2014 FY
Annual report
2 Mar 15
10-Q
2014 Q3
Quarterly report
6 Nov 14
10-Q
2014 Q2
Quarterly report
7 Aug 14
Current reports
8-K
Material Modifications to Rights of Security Holders
31 Oct 16
8-K
Termination of a Material Definitive Agreement
25 Oct 16
8-K
Departure of Directors or Certain Officers
19 Oct 16
8-K
Entry into a Material Definitive Agreement
11 Oct 16
8-K
Horizon Pharma plc to Acquire Raptor Pharmaceutical Corp. as Further Step
12 Sep 16
8-K
Raptor Pharmaceutical Corp. Reports Second Quarter 2016 Financial Results
4 Aug 16
8-K
Termination of a Material Definitive Agreement
7 Jul 16
8-K
Other Events
27 May 16
8-K
Departure of Directors or Certain Officers
13 May 16
8-K
Raptor Pharmaceutical Corp. Reports First Quarter 2016 Financial Results
5 May 16
Registration and prospectus
15-12G
Securities registration termination
4 Nov 16
25-NSE
Exchange delisting
25 Oct 16
POS AM
Prospectus update (post-effective amendment)
25 Oct 16
POS AM
Prospectus update (post-effective amendment)
25 Oct 16
POS AM
Prospectus update (post-effective amendment)
25 Oct 16
POS AM
Prospectus update (post-effective amendment)
25 Oct 16
POS AM
Prospectus update (post-effective amendment)
25 Oct 16
S-8 POS
Registration of securities for employees (post-effective amendment)
25 Oct 16
S-8 POS
Registration of securities for employees (post-effective amendment)
25 Oct 16
S-8 POS
Registration of securities for employees (post-effective amendment)
25 Oct 16
Proxies
DEFA14A
Additional proxy soliciting materials
18 May 15
DEFA14A
Additional proxy soliciting materials
5 May 15
DEFA14A
Additional proxy soliciting materials
26 Mar 15
DEF 14A
Definitive proxy
26 Mar 15
DEFA14A
Additional proxy soliciting materials
29 Jul 14
DEFA14A
Additional proxy soliciting materials
21 Jul 14
DEFA14A
Additional proxy soliciting materials
18 Jun 14
DEF 14A
Definitive proxy
17 Jun 14
DEFA14A
Additional proxy soliciting materials
10 Jun 13
DEF 14A
Definitive proxy
7 Jun 13
Other
CT ORDER
Confidential treatment order
20 Dec 19
CT ORDER
Confidential treatment order
1 Feb 18
EFFECT
Notice of effectiveness
28 Oct 16
EFFECT
Notice of effectiveness
28 Oct 16
EFFECT
Notice of effectiveness
28 Oct 16
EFFECT
Notice of effectiveness
28 Oct 16
EFFECT
Notice of effectiveness
28 Oct 16
EFFECT
Notice of effectiveness
2 May 16
EFFECT
Notice of effectiveness
2 May 16
CORRESP
Correspondence with SEC
15 Mar 16
Ownership
SC 13G/A
Horizon Pharmaceutical LLC
21 Feb 17
SC 13G
Beneficial ownership report
14 Feb 17
SC 13G/A
Horizon Pharmaceutical LLC
13 Jan 17
4
CHRISTOPHER M STARR
26 Oct 16
4
ANTHONY GREGG LAPOINTE
26 Oct 16
4
Suzanne Louise Bruhn
26 Oct 16
4
Julie Smith
26 Oct 16
4
David Happel
26 Oct 16
4
Llew Keltner
26 Oct 16
4
Michael P Smith
26 Oct 16